1.5806
price down icon3.62%   -0.0594
after-market 시간 외 거래: 1.61 0.0294 +1.86%
loading

Adagene Inc Adr 주식(ADAG)의 최신 뉴스

pulisher
Mar 27, 2025

Adagene stock hits 52-week low at $1.62 amid market challenges By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Adagene stock hits 52-week low at $1.62 amid market challenges - Investing.com

Mar 27, 2025
pulisher
Mar 25, 2025

Adagene (ADAG) to Release Quarterly Earnings on Thursday - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

Adagene Reports 33% Overall Response Rate in Phase 2 Expansion of Muzastotug for MSS CRC, Highlights Financial Position and Future Milestones - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

Adagene Reveals Breakthrough Cancer Trial Results in 2024 Financial Update - Stock Titan

Mar 24, 2025
pulisher
Mar 14, 2025

Adagene Inc. (NASDAQ:ADAG) Short Interest Down 55.9% in February - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Adagene to Present at 11th Annual Immuno-Oncology 360⁰ Summit - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Adagene Inc. to Present ADG126 SAFEbody® Data at 11th Annual Immuno-Oncology 360⁰ Summit in Boston - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Adagene's Revolutionary Cancer Treatment Targets CTLA-4: Key Presentation Coming to IO360 Summit - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Adagene to Present at the Leerink Partners Global Biopharma Conference 2024, Business Wires News - AsiaOne

Mar 12, 2025
pulisher
Mar 07, 2025

Adagene Announces Participation At Leerink’s Global Healthcare Conference 2025 - BERNAMA

Mar 07, 2025
pulisher
Mar 07, 2025

Adagene to Present at Leerink’s Global Healthcare Conference 2025 - GlobeNewswire

Mar 07, 2025
pulisher
Mar 06, 2025

Adagene to Present at Leerink's Global Healthcare Conference 2025 - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

Can Adagene's CEO Reveal New Strategic Plans at Upcoming Leerink Conference? - StockTitan

Mar 06, 2025
pulisher
Feb 27, 2025

Adagene Inc. to Initiate Phase 2 Trial of ADG126 for Colorectal Cancer with Enrollment Starting in April 2025 - Nasdaq

Feb 27, 2025
pulisher
Feb 27, 2025

Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal Cancer - GlobeNewswire

Feb 27, 2025
pulisher
Feb 27, 2025

Could This New Colorectal Cancer Trial Change Pre-Surgery Treatment? Adagene Tests ADG126 - StockTitan

Feb 27, 2025
pulisher
Feb 23, 2025

Head to Head Analysis: Rafael (NYSE:RFL) versus Adagene (NASDAQ:ADAG) - Defense World

Feb 23, 2025
pulisher
Feb 16, 2025

Short Interest in Adagene Inc. (NASDAQ:ADAG) Declines By 50.2% - MarketBeat

Feb 16, 2025
pulisher
Feb 13, 2025

Adagene Inc. (NASDAQ:ADAG) Short Interest Update - Defense World

Feb 13, 2025
pulisher
Feb 13, 2025

Head to Head Survey: Adagene (NASDAQ:ADAG) and Corvus Pharmaceuticals (NASDAQ:CRVS) - Defense World

Feb 13, 2025
pulisher
Feb 04, 2025

Morgan Stanley Downgrades Adagene (NASDAQ:ADAG) to Equal Weight - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Adagene Inc. (NASDAQ:ADAG) Sees Large Increase in Short Interest - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Adagene (NASDAQ:ADAG) Cut to “Equal Weight” at Morgan Stanley - Defense World

Feb 03, 2025
pulisher
Feb 01, 2025

FY2024 Earnings Estimate for Adagene Issued By HC Wainwright - MarketBeat

Feb 01, 2025
pulisher
Jan 31, 2025

HC Wainwright Estimates Adagene FY2029 Earnings - MarketBeat

Jan 31, 2025
pulisher
Jan 31, 2025

Morgan Stanley Downgrades Adagene to Equal Weight From Overweight -January 31, 2025 at 07:57 am EST - Marketscreener.com

Jan 31, 2025
pulisher
Jan 31, 2025

Adagene Inc. (NASDAQ:ADAG) Sees Significant Growth in Short Interest - Defense World

Jan 31, 2025
pulisher
Jan 30, 2025

Adagene Reports Promising Results in Colorectal Cancer Study - TipRanks

Jan 30, 2025
pulisher
Jan 29, 2025

FY2029 Earnings Forecast for Adagene Issued By HC Wainwright - Defense World

Jan 29, 2025
pulisher
Jan 28, 2025

Adagene Announces Updated Data from Phase 1b/2 Study of - GlobeNewswire

Jan 28, 2025
pulisher
Jan 27, 2025

Adagene (NASDAQ:ADAG) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat

Jan 27, 2025
pulisher
Jan 27, 2025

H.C. Wainwright lifts Adagene stock target to $8 on ASCO data - Investing.com

Jan 27, 2025
pulisher
Jan 27, 2025

Adagene reports positive colorectal cancer trial results - Investing.com India

Jan 27, 2025
pulisher
Jan 27, 2025

ADAGAdagene Inc. American Depositary Shares Latest Stock News & Market Updates - StockTitan

Jan 27, 2025
pulisher
Jan 27, 2025

Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium - The Manila Times

Jan 27, 2025
pulisher
Jan 27, 2025

Adagene's Muzastotug Shows 33% Response Rate in Colorectal Cancer Trial - StockTitan

Jan 27, 2025
pulisher
Jan 22, 2025

Adagene to present new ADG126 clinical data at ASCO-GI - MSN

Jan 22, 2025
pulisher
Jan 22, 2025

Adagene to present new ADG126 clinical data at ASCO-GI By Investing.com - Investing.com Australia

Jan 22, 2025
pulisher
Jan 22, 2025

Adagene to Announce Updated Data from Phase 1b/2 Study of - GlobeNewswire

Jan 22, 2025
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):